Roswell Park Reports Positive Outcomes From New Combination Treatment for Ovarian Cancer
November 20, 2020
November 20, 2020
BUFFALO, New York, Nov. 20 (TNSJou) -- The Roswell Park Comprehensive Cancer Center issued the following news release:
A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.
In a new article in JAMA Oncology, the researchers report that one-quarter of patients who received the combination of pembrolizumab (brand name Keytr . . .
A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.
In a new article in JAMA Oncology, the researchers report that one-quarter of patients who received the combination of pembrolizumab (brand name Keytr . . .